Mostrando resultados 139 a 158 de 215
< Anterior
Siguiente >
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| closedAccess |  | 2011 | P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer | Montero, Juan Carlos CSIC ORCID; Seoane, Samuel CSIC ORCID; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2019 | Paclitaxel-trastuzumab mixed nanovehicle to target HER2-overexpressing tumors | Nieto, Celia; Centa, Ariana; Rodríguez-Rodríguez, Jesús A.; Pandiella, Atanasio CSIC ORCID CVN ; Martín del Valle, Eva María | artículo |
| closedAccess |  | 2020 | PDCD4 limits prooncogenic neuregulin-ErbB signaling | Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 29-jul-2010 | Personalized therapies in the cancer "omics" era | Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2020 | Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer | Corrales-Sánchez, Verónica; Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Pérez-Peña, Javier; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2015 | Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors | Serrano-Heras, Gemma CSIC ORCID; Cuenca-López, María D.; Montero, Juan Carlos CSIC ORCID; Morales, Jorge C.; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 30-abr-2014 | Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling | Cuenca-López, María D.; Montero, Juan Carlos CSIC ORCID; Morales, Jorge C.; Prat, Aleix; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| closedAccess |  | 2013 | Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells | Montero, Juan Carlos CSIC ORCID; Seoane, Samuel CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2013 | Potent antimyeloma activity of a novel ERK5/CDK inhibitor | Álvarez-Fernández, Stela CSIC; Ortiz-Ruiz, María Jesús CSIC; Parrott, Tracy; Zaknoen, Sara; Ocio, Enrique M. CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; Burrows, Francis J.; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 15-sep-2021 | Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancer | Guardia, Cristina; Bianchini, Giampaolo; Arpí, Oriol; Menendez, Silvia; Casadevall, David; Galbardi, Barbara; Dugo, Matteo; Servitja, Sonia; Montero, Juan Carlos CSIC ORCID; Soria-Jiménez, Luis; Sabbaghi, Mohammad A.; Peña, Raúl; Madoz-Gúrpide, Juan CSIC ORCID; Lloveras, Belén; Lluch, Ana; Eroles, Pilar; Arribas, Joaquín; Pandiella, Atanasio CSIC ORCID CVN ; Gianni, Luca; Rojo, Federico; Rovira, Ana; Albanell, Joan | artículo |
| closedAccess |  | 2011 | Preclinical development of molecular-targeted agents for cancer | Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2012 | Predominance of mTORC1 over mTORC2 in the regulation of proliferation of ovarian cancer cells: Therapeutic implications | Montero, Juan Carlos CSIC ORCID; Chen, Xi CSIC; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2014 | Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis | Seruga, Bostjan; Amir, Eitan; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2019 | Prognostic value of Lymphocyte-Activation Gene 3 (LAG3) in cancer: A meta-analysis | Saleh, Ramy R.; Peinado, Paloma; Fuentes-Antrás, Jesús; Pérez-Segura, Pedro; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Alberto | artículo |
| openAccess |  | 19-ene-2022 | Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis | Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Alberto | artículo |
| openAccess |  | 2020 | Proteolysis targeting chimeras (PROTACs) in cancer therapy | Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo de revisión |
| closedAccess |  | 2013 | RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications | García-Gómez, Antonio; Ocio, Enrique M. CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID | artículo |
| openAccess | | 2012 | Receptores tirosina quinasa en cáncer | Pandiella, Atanasio CSIC ORCID CVN | material didáctico |
| closedAccess |  | nov-2018 | Refining Early Antitumoral Drug Development | Ocaña, Alberto; García-Alonso, Sara; Amir, Eitan; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2017 | Regulation of the prometastatic neuregulin–MMP13 axis by SRC family kinases: therapeutic implications | Orive-Ramos, Ana CSIC; Seoane, Samuel CSIC ORCID; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN ; Montero, Juan Carlos CSIC ORCID | artículo |
